Interaction between the Type III Effector VopO and GEF-H1 Activates the RhoA-ROCK Pathway

PLoS Pathogens

Volumn 11, Issue 3, 2015, Pages 1-19

  Hiyoshi, Hirotaka ^a   Okada, Ryu ^a   Matsuda, Shigeaki ^a   Gotoh, Kazuyoshi ^a   Akeda, Yukihiro ^a   Iida, Tetsuya ^a   Kodama, Toshio ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE EXCHANGE FACTOR H1; MYOSIN LIGHT CHAIN; NOCODAZOLE; PEPTIDES AND PROTEINS; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR; ROCK PROTEIN; SMALL INTERFERING RNA; TYPE III EFFECTOR VOPO; TYPE III SECRETION SYSTEM ENCODED ON CHROMOSOME 2; UNCLASSIFIED DRUG; ACTIN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ALPHA HELIX; ARTICLE; BACTERIAL STRAIN; BINDING AFFINITY; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; MICROTUBULE; NONHUMAN; PHOSPHORYLATION; PLASMID; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STRESS FIBER; VIBRIO PARAHAEMOLYTICUS; WESTERN BLOTTING; METABOLISM; PHYSIOLOGY;

BACTERIA (MICROORGANISMS); VIBRIO PARAHAEMOLYTICUS;

ACTINS; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; MICROTUBULES; RHO GUANINE NUCLEOTIDE EXCHANGE FACTORS; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; VIBRIO PARAHAEMOLYTICUS;

EID: 84926509356     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004694     Document Type: Article

References (51)

1. Nair GB, Ramamurthy T, Bhattacharya SK, Dutta B, Takeda Y, et al. (2007) Global dissemination of Vibrio parahaemolyticus serotype O3:K6 and its serovariants. Clin Microbiol Rev 20: 39–48. 17223622
2. Makino K, Oshima K, Kurokawa K, Yokoyama K, Uda T, et al. (2003) Genome sequence of Vibrio parahaemolyticus: a pathogenic mechanism distinct from that of V cholerae. Lancet 361: 743–749. 12620739
3. Galan JE, (2009) Common themes in the design and function of bacterial effectors. Cell Host Microbe 5: 571–579. doi: 10.1016/j.chom.2009.04.008 19527884
4. Hiyoshi H, Kodama T, Iida T, Honda T, (2010) Contribution of Vibrio parahaemolyticus virulence factors to cytotoxicity, enterotoxicity, and lethality in mice. Infect Immun 78: 1772–1780. doi: 10.1128/IAI.01051-09 20086084
5. Ritchie JM, Rui H, Zhou X, Iida T, Kodoma T, et al. (2012) Inflammation and disintegration of intestinal villi in an experimental model for Vibrio parahaemolyticus-induced diarrhea. PLoS Pathog 8: e1002593. doi: 10.1371/journal.ppat.1002593 22438811
6. Nakano M, Takahashi A, Sakai Y, Nakaya Y, (2007) Modulation of pathogenicity with norepinephrine related to the type III secretion system of Vibrio parahaemolyticus. J Infect Dis 195: 1353–1360. 17397007
7. Okada R, Zhou X, Hiyoshi H, Matsuda S, Chen X, et al. (2014) The Vibrio parahaemolyticus effector VopC mediates Cdc42-dependent invasion of cultured cells but is not required for pathogenicity in an animal model of infection. Cell Microbiol 16: 938–947. doi: 10.1111/cmi.12252 24345190
8. Okada N, Iida T, Park KS, Goto N, Yasunaga T, et al. (2009) Identification and characterization of a novel type III secretion system in trh-positive Vibrio parahaemolyticus strain TH3996 reveal genetic lineage and diversity of pathogenic machinery beyond the species level. Infect Immun 77: 904–913. doi: 10.1128/IAI.01184-08 19075025
9. Izutsu K, Kurokawa K, Tashiro K, Kuhara S, Hayashi T, et al. (2008) Comparative genomic analysis using microarray demonstrates a strong correlation between the presence of the 80-kilobase pathogenicity island and pathogenicity in Kanagawa phenomenon-positive Vibrio parahaemolyticus strains. Infect Immun 76: 1016–1023. doi: 10.1128/IAI.01535-07 18195030
10. Hiyoshi H, Kodama T, Saito K, Gotoh K, Matsuda S, et al. (2011) VopV, an F-actin-binding type III secretion effector, is required for Vibrio parahaemolyticus-induced enterotoxicity. Cell Host Microbe 10: 401–409. doi: 10.1016/j.chom.2011.08.014 22018240
11. Wilson BA, Ho M, (2010) Recent insights into Pasteurella multocida toxin and other G-protein-modulating bacterial toxins. Future Microbiol 5: 1185–1201. doi: 10.2217/fmb.10.91 20722598
12. Liverman AD, Cheng HC, Trosky JE, Leung DW, Yarbrough ML, et al. (2007) Arp2/3-independent assembly of actin by Vibrio type III effector VopL. Proc Natl Acad Sci U S A 104: 17117–17122. 17942696
13. Zhou X, Gewurz BE, Ritchie JM, Takasaki K, Greenfeld H, et al. (2013) A Vibrio parahaemolyticus T3SS effector mediates pathogenesis by independently enabling intestinal colonization and inhibiting TAK1 activation. Cell Rep 3: 1690–1702. doi: 10.1016/j.celrep.2013.03.039 23623501
14. Dean P, (2011) Functional domains and motifs of bacterial type III effector proteins and their roles in infection. FEMS Microbiol Rev 35: 1100–1125. doi: 10.1111/j.1574-6976.2011.00271.x 21517912
15. Bulgin R, Raymond B, Garnett JA, Frankel G, Crepin VF, et al. (2010) Bacterial guanine nucleotide exchange factors SopE-like and WxxxE effectors. Infect Immun 78: 1417–1425. doi: 10.1128/IAI.01250-09 20123714
16. Chavan A, Rosenthal H, Luthe L, Pfingsten S, Kutschka I, et al. (2009) Percutaneous interventions for treating ischemic complications of aortic dissection. Eur Radiol 19: 488–494. doi: 10.1007/s00330-008-1141-4 18690447
17. Ridley AJ, (2006) Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking. Trends Cell Biol 16: 522–529. 16949823
18. Narumiya S, (1996) The small GTPase Rho: cellular functions and signal transduction. J Biochem 120: 215–228. 8889802
19. Totsukawa G, Yamakita Y, Yamashiro S, Hartshorne DJ, Sasaki Y, et al. (2000) Distinct roles of ROCK (Rho-kinase) and MLCK in spatial regulation of MLC phosphorylation for assembly of stress fibers and focal adhesions in 3T3 fibroblasts. J Cell Biol 150: 797–806. 10953004
20. Gotoh K, Kodama T, Hiyoshi H, Izutsu K, Park KS, et al. (2010) Bile acid-induced virulence gene expression of Vibrio parahaemolyticus reveals a novel therapeutic potential for bile acid sequestrants. PLoS One 5: e13365. doi: 10.1371/journal.pone.0013365 20967223
21. Kodama T, Hiyoshi H, Gotoh K, Akeda Y, Matsuda S, et al. (2008) Identification of two translocon proteins of Vibrio parahaemolyticus type III secretion system 2. Infect Immun 76: 4282–4289. doi: 10.1128/IAI.01738-07 18541652
22. Kodama T, Rokuda M, Park KS, Cantarelli VV, Matsuda S, et al. (2007) Identification and characterization of VopT, a novel ADP-ribosyltransferase effector protein secreted via the Vibrio parahaemolyticus type III secretion system 2. Cell Microbiol 9: 2598–2609. 17645751
23. Zhang L, Krachler AM, Broberg CA, Li Y, Mirzaei H, et al. (2012) Type III effector VopC mediates invasion for Vibrio species. Cell Rep 1: 453–460. doi: 10.1016/j.celrep.2012.04.004 22787576
24. Birukova AA, Smurova K, Birukov KG, Usatyuk P, Liu F, et al. (2004) Microtubule disassembly induces cytoskeletal remodeling and lung vascular barrier dysfunction: role of Rho-dependent mechanisms. J Cell Physiol 201: 55–70. 15281089
25. Rossman KL, Der CJ, Sondek J, (2005) GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat Rev Mol Cell Biol 6: 167–180. 15688002
26. Guilluy C, Swaminathan V, Garcia-Mata R, O’Brien ET, Superfine R, et al. (2011) The Rho GEFs LARG and GEF-H1 regulate the mechanical response to force on integrins. Nat Cell Biol 13: 722–727. doi: 10.1038/ncb2254 21572419
27. Cario-Toumaniantz C, Ferland-McCollough D, Chadeuf G, Toumaniantz G, Rodriguez M, et al. (2012) RhoA guanine exchange factor expression profile in arteries: evidence for a Rho kinase-dependent negative feedback in angiotensin II-dependent hypertension. Am J Physiol Cell Physiol 302: C1394–1404. doi: 10.1152/ajpcell.00423.2011 22322975
28. Matsuzawa T, Kuwae A, Yoshida S, Sasakawa C, Abe A, (2004) Enteropathogenic Escherichia coli activates the RhoA signaling pathway via the stimulation of GEF-H1. EMBO J 23: 3570–3582. 15318166
29. Birkenfeld J, Nalbant P, Yoon SH, Bokoch GM, (2008) Cellular functions of GEF-H1, a microtubule-regulated Rho-GEF: is altered GEF-H1 activity a crucial determinant of disease pathogenesis? Trends Cell Biol 18: 210–219. doi: 10.1016/j.tcb.2008.02.006 18394899
30. Krendel M, Zenke FT, Bokoch GM, (2002) Nucleotide exchange factor GEF-H1 mediates cross-talk between microtubules and the actin cytoskeleton. Nat Cell Biol 4: 294–301. 11912491
31. Shaw RK, Smollett K, Cleary J, Garmendia J, Straatman-Iwanowska A, et al. (2005) Enteropathogenic Escherichia coli type III effectors EspG and EspG2 disrupt the microtubule network of intestinal epithelial cells. Infect Immun 73: 4385–4390. 15972534
32. Tomson FL, Viswanathan VK, Kanack KJ, Kanteti RP, Straub KV, et al. (2005) Enteropathogenic Escherichia coli EspG disrupts microtubules and in conjunction with Orf3 enhances perturbation of the tight junction barrier. Mol Microbiol 56: 447–464. 15813736
33. Ulluwishewa D, Anderson RC, McNabb WC, Moughan PJ, Wells JM, et al. (2011) Regulation of tight junction permeability by intestinal bacteria and dietary components. J Nutr 141: 769–776. doi: 10.3945/jn.110.135657 21430248
34. Khounlotham M, Kim W, Peatman E, Nava P, Medina-Contreras O, et al. (2012) Compromised intestinal epithelial barrier induces adaptive immune compensation that protects from colitis. Immunity 37: 563–573. doi: 10.1016/j.immuni.2012.06.017 22981539
35. Guttman JA, Finlay BB, (2009) Tight junctions as targets of infectious agents. Biochim Biophys Acta 1788: 832–841. doi: 10.1016/j.bbamem.2008.10.028 19059200
36. Hopkins AM, Walsh SV, Verkade P, Boquet P, Nusrat A, (2003) Constitutive activation of Rho proteins by CNF-1 influences tight junction structure and epithelial barrier function. J Cell Sci 116: 725–742. 12538773
37. Schlegel N, Meir M, Spindler V, Germer CT, Waschke J, (2011) Differential role of Rho GTPases in intestinal epithelial barrier regulation in vitro. J Cell Physiol 226: 1196–1203. doi: 10.1002/jcp.22446 20945370
38. Matsuzawa T, Kuwae A, Abe A, (2005) Enteropathogenic Escherichia coli type III effectors EspG and EspG2 alter epithelial paracellular permeability. Infect Immun 73: 6283–6289. 16177299
39. Matsumura T, Jin Y, Kabumoto Y, Takegahara Y, Oguma K, et al. (2008) The HA proteins of botulinum toxin disrupt intestinal epithelial intercellular junctions to increase toxin absorption. Cell Microbiol 10: 355–364. 17868282
40. Kaverina I, Krylyshkina O, Small JV, (2002) Regulation of substrate adhesion dynamics during cell motility. Int J Biochem Cell Biol 34: 746–761. 11950592
41. Guo F, Debidda M, Yang L, Williams DA, Zheng Y, (2006) Genetic deletion of Rac1 GTPase reveals its critical role in actin stress fiber formation and focal adhesion complex assembly. J Biol Chem 281: 18652–18659. 16698790
42. Sawada N, (2013) Tight junction-related human diseases. Pathol Int 63: 1–12. doi: 10.1111/pin.12021 23356220
43. de Souza Santos M, Orth K, (2014) Intracellular Vibrio parahaemolyticus escapes the vacuole and establishes a replicative niche in the cytosol of epithelial cells. MBio 5: e01506–01514. doi: 10.1128/mBio.01506-14 25205094
44. Akeda Y, Nagayama K, Yamamoto K, Honda T, (1997) Invasive phenotype of Vibrio parahaemolyticus. J Infect Dis 176: 822–824. 9291344
45. Orchard RC, Alto NM, (2012) Mimicking GEFs: a common theme for bacterial pathogens. Cell Microbiol 14: 10–18. doi: 10.1111/j.1462-5822.2011.01703.x 21951829
46. Meiri D, Marshall CB, Greeve MA, Kim B, Balan M, et al. (2012) Mechanistic insight into the microtubule and actin cytoskeleton coupling through dynein-dependent RhoGEF inhibition. Mol Cell 45: 642–655. doi: 10.1016/j.molcel.2012.01.027 22405273
47. Yoshimura Y, Miki H, (2011) Dynamic regulation of GEF-H1 localization at microtubules by Par1b/MARK2. Biochem Biophys Res Commun 408: 322–328. doi: 10.1016/j.bbrc.2011.04.032 21513698
48. Fujishiro SH, Tanimura S, Mure S, Kashimoto Y, Watanabe K, et al. (2008) ERK1/2 phosphorylate GEF-H1 to enhance its guanine nucleotide exchange activity toward RhoA. Biochem Biophys Res Commun 368: 162–167. doi: 10.1016/j.bbrc.2008.01.066 18211802
49. Zenke FT, Krendel M, DerMardirossian C, King CC, Bohl BP, et al. (2004) p21-activated kinase 1 phosphorylates and regulates 14–3–3 binding to GEF-H1, a microtubule-localized Rho exchange factor. J Biol Chem 279: 18392–18400. 14970201
50. Callow MG, Zozulya S, Gishizky ML, Jallal B, Smeal T, (2005) PAK4 mediates morphological changes through the regulation of GEF-H1. J Cell Sci 118: 1861–1872. 15827085
51. Chang YC, Nalbant P, Birkenfeld J, Chang ZF, Bokoch GM, (2008) GEF-H1 couples nocodazole-induced microtubule disassembly to cell contractility via RhoA. Mol Biol Cell 19: 2147–2153. doi: 10.1091/mbc.E07-12-1269 18287519